VONKO-018: Rezidive bei Patient*innen mit HR+/HER2- Brustkrebs im Frühstadium

Waldmann, Annika (Principal Investigator (PI))
Grieger, Paula (Project Staff)
Baltus, Hannah (Project Staff)
Katalinic, Alexander (Co-PI)

Project: Industrial Collaboration and Development › Industrial Collaboration

Short title	VONKO-018 eBC
Status	Active
Effective start/end date	01.04.24 → …

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

SDG 3 Good Health and Well-being

Funding Institution

Industrial Collaboration

Research Areas and Centers

Research Area: Center for Population Medicine and Public Health (ZBV)

DFG Research Classification Scheme

2.22-02 Public Health, Healthcare Research, Social and Occupational Medicine
2.22-14 Hematology, Oncology

Individual Keywords of Research Units and Groups

Population Medicine FB2

ASJC Subject Areas

Oncology
Obstetrics and Gynaecology

Project Details

VONKO-028: Das Rezidivrisiko bei Patientinnen mit invasivem Mammakarzinom – Eine explorative Analyse auf Basis der PATH-Biobank
Waldmann, A. (Principal Investigator (PI)) & Grieger, P. (Project Staff)
01.07.25 → …
Project: Projects with in-house funding

VONKO-018: Rezidive bei Patient*innen mit HR+/HER2- Brustkrebs im Frühstadium

Project Details

UN Sustainable Development Goals

Funding Institution

Research Areas and Centers

DFG Research Classification Scheme

Individual Keywords of Research Units and Groups

ASJC Subject Areas

Project Details

Projects

VONKO-028: Das Rezidivrisiko bei Patientinnen mit invasivem Mammakarzinom – Eine explorative Analyse auf Basis der PATH-Biobank